These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 20877272)
1. Characteristics and prognosis of post-transplant lymphoproliferative disorders within renal allograft: Report from the PTLD.Int. Survey. Khedmat H; Taheri S Ann Transplant; 2010; 15(3):80-6. PubMed ID: 20877272 [TBL] [Abstract][Full Text] [Related]
2. Early onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies. Khedmat H; Taheri S Ann Transplant; 2009; 14(3):74-7. PubMed ID: 19644164 [TBL] [Abstract][Full Text] [Related]
3. Bone marrow involvement by lymphoproliferative disorders after renal transplantation: PTLD. Int. Survey. Izadi M; Fazel M; Saadat SH; Taheri S J Cancer Res Ther; 2012; 8(1):62-7. PubMed ID: 22531516 [TBL] [Abstract][Full Text] [Related]
4. Small intestinal involvement by lymphoproliferative disorders post-renal transplantation: a report from the post-transplant lymphoproliferative disorder international survey. Khedmat H; Taheri S Saudi J Kidney Dis Transpl; 2013 May; 24(3):487-94. PubMed ID: 23640619 [TBL] [Abstract][Full Text] [Related]
5. Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793 [TBL] [Abstract][Full Text] [Related]
6. An approach to finding indications and contraindications for nephrectomy in post-transplant renal graft lymphomas: PTLD.Int survey. Gholipour-Shoiili A; Gholipour-Shoiili H; Taheri S Hematol Oncol Stem Cell Ther; 2011; 4(4):167-72. PubMed ID: 22198192 [TBL] [Abstract][Full Text] [Related]
7. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey. Khedmat H; Taheri S Ann Transplant; 2011; 16(1):109-16. PubMed ID: 21436784 [TBL] [Abstract][Full Text] [Related]
8. Features, predictors and prognosis of lymphoproliferative disorders post-liver transplantation regarding disease presentation time: report from the PTLD.Int. survey. Izadi M; Taheri S Ann Transplant; 2011; 16(1):39-47. PubMed ID: 21436773 [TBL] [Abstract][Full Text] [Related]
10. Post-transplantation lymphoproliferative disorders in renal vs. simultaneous renal-pancreas allograft recipients: a survey and analysis of data from the literature. Khedmat H; Taheri S Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):1-7. PubMed ID: 23354184 [TBL] [Abstract][Full Text] [Related]
11. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey. Khedmat H; Taheri S Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371 [TBL] [Abstract][Full Text] [Related]
12. Very late onset lymphoproliferative disorders occurring over 10 years post-renal transplantation: PTLD.Int. Survey. Khedmat H; Taheri S Hematol Oncol Stem Cell Ther; 2011; 4(2):73-80. PubMed ID: 21727768 [TBL] [Abstract][Full Text] [Related]
14. Allograft involvement by lymphoproliferative disorders after lung transplantation: report from the PTLD. Int survey. Izadi M; Taheri S Prog Transplant; 2011 Dec; 21(4):353-9. PubMed ID: 22549000 [TBL] [Abstract][Full Text] [Related]
16. Hepatic lymphomas post renal transplantation may signify worse disease behavior: analysis of data from 26 international studies. Khedmat H; Taheri S Arab J Nephrol Transplant; 2011 Sep; 4(3):109-16. PubMed ID: 22026333 [TBL] [Abstract][Full Text] [Related]
17. Late onset post transplantation lymphoproliferative disorders: analysis of international data from 5 studies. Khedmat H; Taheri S Ann Transplant; 2009; 14(4):80-5. PubMed ID: 20009160 [TBL] [Abstract][Full Text] [Related]
18. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. Caillard S; Porcher R; Provot F; Dantal J; Choquet S; Durrbach A; Morelon E; Moal V; Janbon B; Alamartine E; Pouteil Noble C; Morel D; Kamar N; Buchler M; Mamzer MF; Peraldi MN; Hiesse C; Renoult E; Toupance O; Rerolle JP; Delmas S; Lang P; Lebranchu Y; Heng AE; Rebibou JM; Mousson C; Glotz D; Rivalan J; Thierry A; Etienne I; Moal MC; Albano L; Subra JF; Ouali N; Westeel PF; Delahousse M; Genin R; Hurault de Ligny B; Moulin B J Clin Oncol; 2013 Apr; 31(10):1302-9. PubMed ID: 23423742 [TBL] [Abstract][Full Text] [Related]
19. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study. OʼRegan JA; Prendeville S; McCaughan JA; Traynor C; OʼBrien FJ; Ward FL; OʼDonovan D; Kennedy C; Berzan E; Kinsella S; Williams Y; OʼKelly P; Deady S; Comber H; Leader M; Conlon PJ Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265 [TBL] [Abstract][Full Text] [Related]
20. Characteristics and prognosis of lymphoproliferative disorders post-renal transplantation in living versus deceased donor allograft recipients. Khedmat H; Taheri S Saudi J Kidney Dis Transpl; 2013 Sep; 24(5):903-9. PubMed ID: 24029253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]